Global Biopharmaceutical Manufacturing Market to Reach US$ 935.0 Billion by 2032, Propelled by the Growing Demand for Biologic Drugs

May 29, 2023 | Healthcare

The latest report by IMARC Group, titled "Biopharmaceutical Manufacturing Market Report by Cell Culture (Mammalian Cell Culture, Microbial Cell Culture), Class (Monoclonal Antibodies, Recombinant Proteins, Interferon, Granulocyte Colony-Stimulating Factor (G-CSF), Erythropoietin, Recombinant Human Insulin, Vaccines, Human Growth Hormones (HGH)), and Region 2024-2032," finds that the global biopharmaceutical manufacturing market size reached US$ 411.8 Billion in 2023. Biopharmaceutical manufacturing refers to the process of producing pharmaceutical products, such as drugs and therapies, that are derived from biological sources. Unlike traditional pharmaceutical manufacturing, which involves chemical synthesis, biopharmaceutical manufacturing utilizes living organisms, cells, or their components to produce therapeutic substances. It involves various steps, including cell culture, fermentation, purification, and formulation, to produce biologically active molecules like proteins, antibodies, enzymes, or nucleic acids. The manufacturing process requires stringent quality control, adherence to Good Manufacturing Practices (GMP), and regulatory compliance to ensure safety, efficacy, and purity of biopharmaceutical products. Biopharmaceutical manufacturing plays a crucial role in providing innovative and effective treatments for various diseases, including cancer, autoimmune disorders, and genetic conditions.

Global Biopharmaceutical Manufacturing Market Trends:

One of the primary factors driving the market is the growing demand for biologic drugs, including monoclonal antibodies, vaccines, and recombinant proteins. Biologics offer targeted and personalized treatment options for various diseases, leading to an increase in the adoption of biopharmaceutical manufacturing. Additionally, the rising incidence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, has fueled the demand for innovative and targeted therapies. Biopharmaceuticals have shown promising results in the treatment of these diseases, leading to rising investment in biopharmaceutical manufacturing to meet the growing market needs. Other than this, numerous biopharmaceutical companies are outsourcing their manufacturing activities to specialized contract manufacturing organizations (CMOs), as outsourcing allows companies to access specialized expertise, reduce costs, and focus on their core competencies. Besides this, advances in biotechnology, such as genetic engineering, cell culture technologies, and bioprocessing techniques, have significantly improved the production efficiency and scalability of biopharmaceuticals. These advancements have enabled the development of complex and highly effective biologic drugs, stimulating the growth of the biopharmaceutical manufacturing market. Furthermore, regulatory agencies have implemented supportive policies and guidelines to streamline the approval process for biological drugs. This has encouraged biopharmaceutical companies to invest in manufacturing infrastructure and expand their production capacities, thus impelling the market growth. Moreover, continuous improvements in manufacturing processes, such as single-use technologies, process automation, and advanced analytics, have enhanced productivity, efficiency, and cost-effectiveness in biopharmaceutical manufacturing. These advancements have contributed to the expansion of manufacturing capacities. On account of these factors, IMARC Group expects the market value to reach US$ 935.0 Billion by 2032, exhibiting a CAGR of 9.3% during the forecast period (2024-2032). 

Market Summary:

  • On the basis of the cell culture, the market has been segmented into mammalian and microbial. At present, mammalian cells represent the largest segment.
  • Based on the class, the market has been categorized into monoclonal antibodies, recombinant proteins, interferon, granulocyte colony-stimulating factor (G-CSF), erythropoietin, recombinant human insulin, vaccines, and human growth hormones (HGH). Presently, monoclonal antibodies account for the majority of the market share.
  • Region-wise, North America holds the leading position in the market. Other major regions include Asia and Europe.
  • The competitive landscape of the market has been examined in the report, with some of the key players being AbbVie Inc., Amgen Inc., Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Novo Nordisk A/S, Pfizer Inc. and Sanofi S.A.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units Kilo Liters
Cell Cultures Covered Mammalian, Microbial
Classes Covered Monoclonal Antibodies, Recombinant Proteins, Interferon, Granulocyte Colony-Stimulating Factor (G-CSF), Erythropoietin, Recombinant Human Insulin, Vaccines, Human Growth Hormones (HGH)
Region Covered North America, Europe, Asia
Companies Covered AbbVie Inc., Amgen Inc., Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Novo Nordisk A/S, Pfizer Inc. and Sanofi S.A.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Biopharmaceutical Manufacturing Market to Reach US$ 935.0 Billion by 2032, Propelled by the Growing Demand for Biologic Drugs
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More